90 related articles for article (PubMed ID: 30976111)
21. A milder form of NSRP1-associated neurodevelopmental disorder, caused by a missense variant in the nuclear localization signal.
Neuens S; Kausar M; Kang SK; Soblet J; Van Dooren S; Olsen C; Janssen T; Caljon B; Jun CD; Smits G; Coppens S; Vilain C
Am J Med Genet A; 2024 May; ():e63727. PubMed ID: 38808951
[TBL] [Abstract][Full Text] [Related]
22. Clinical and ocular abnormalities in DEGCAGS syndrome-Developmental delay with gastrointestinal, cardiovascular, genitourinary, and skeletal abnormalities.
Ali SM; AlMasri DA; Prada CE; Lin D; Bosley TM; Kozak I
Mol Genet Genomic Med; 2024 Jan; 12(1):e2329. PubMed ID: 38014480
[TBL] [Abstract][Full Text] [Related]
23. A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of
Flannery KP; Safwat S; Matsell E; Battula N; Hamed AAA; Mohamed IN; Elseed MA; Koko M; Abubaker R; Abozar F; Elsayed LEO; Bhise V; Molday RS; Salih MA; Yahia A; Manzini MC
medRxiv; 2024 May; ():. PubMed ID: 38798571
[TBL] [Abstract][Full Text] [Related]
24. Biallelic loss-of-function variants of ZFTRAF1 cause neurodevelopmental disorder with microcephaly and hypotonia.
Asif M; Khayyat AIA; Alawbathani S; Abdullah U; Sanner A; Georgomanolis T; Haasters J; Becker K; Budde B; Becker C; Thiele H; Baig SM; Isidoro-García M; Winter D; Pogoda HM; Muhammad S; Hammerschmidt M; Kraft F; Kurth I; Martin HG; Wagner M; Nürnberg P; Hussain MS
Genet Med; 2024 Apr; 26(7):101143. PubMed ID: 38641995
[TBL] [Abstract][Full Text] [Related]
25. Novel missense variants cause intermediate phenotypes in the phenotypic spectrum of SLC5A6-related disorders.
Utsuno Y; Hamada K; Hamanaka K; Miyoshi K; Tsuchimoto K; Sunada S; Itai T; Sakamoto M; Tsuchida N; Uchiyama Y; Koshimizu E; Fujita A; Miyatake S; Misawa K; Mizuguchi T; Kato Y; Saito K; Ogata K; Matsumoto N
J Hum Genet; 2024 Feb; 69(2):69-77. PubMed ID: 38012394
[TBL] [Abstract][Full Text] [Related]
26. Ca2+-induced release of IQSEC2/BRAG1 autoinhibition under physiological and pathological conditions.
Bai G; Li H; Qin P; Guo Y; Yang W; Lian Y; Ye F; Chen J; Wu M; Huang R; Li J; Lu Y; Zhang M
J Cell Biol; 2023 Dec; 222(12):. PubMed ID: 37787765
[TBL] [Abstract][Full Text] [Related]
27. De novo missense variants in exon 9 of SEPHS1 cause a neurodevelopmental condition with developmental delay, poor growth, hypotonia, and dysmorphic features.
Mullegama SV; Kiernan KA; Torti E; Pavlovsky E; Tilton N; Sekula A; Gao H; Alaimo JT; Engleman K; Rush ET; Blocker K; Dipple KM; Fettig VM; Hare H; Glass I; Grange DK; Griffin M; Phornphutkul C; Massingham L; Mehta L; Miller DE; Thies J; Merritt JL; Muller E; Osmond M; Sawyer SL; Slaugh R; Hickey RE; Wolf B; ; ; Choudhary S; Simonović M; Zhang Y; Palculict TB; Telegrafi A; Carere DA; Wentzensen IM; Morrow MM; Monaghan KG; Juusola J; Yang J
Am J Hum Genet; 2024 Jun; 111(6):1240. PubMed ID: 38749428
[No Abstract] [Full Text] [Related]
28. Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging.
Hou YC; Yu HC; Martin R; Cirulli ET; Schenker-Ahmed NM; Hicks M; Cohen IV; Jönsson TJ; Heister R; Napier L; Swisher CL; Dominguez S; Tang H; Li W; Perkins BA; Barea J; Rybak C; Smith E; Duchicela K; Doney M; Brar P; Hernandez N; Kirkness EF; Kahn AM; Venter JC; Karow DS; Caskey CT
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):3053-3062. PubMed ID: 31980526
[TBL] [Abstract][Full Text] [Related]
29. Heterozygous loss-of-function variants in DOCK4 cause neurodevelopmental delay and microcephaly.
Herbst C; Bothe V; Wegler M; Axer-Schaefer S; Audebert-Bellanger S; Gecz J; Cogne B; Feldman HB; Horn AHC; Hurst ACE; Kelly MA; Kruer MC; Kurolap A; Laquerriere A; Li M; Mark PR; Morawski M; Nizon M; Pastinen T; Polster T; Saugier-Veber P; SeSong J; Sticht H; Stieler JT; Thifffault I; van Eyk CL; Marcorelles P; Vezain-Mouchard M; Abou Jamra R; Oppermann H
Hum Genet; 2024 Mar; 143(3):455-469. PubMed ID: 38526744
[TBL] [Abstract][Full Text] [Related]
30.
Alexander MS; Velinov M
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895289
[TBL] [Abstract][Full Text] [Related]
31. Loss of ZBED6 Protects Against Sepsis-Induced Muscle Atrophy by Upregulating DOCK3-Mediated RAC1/PI3K/AKT Signaling Pathway in Pigs.
Liu H; Pan D; Li P; Wang D; Xia B; Zhang R; Lu J; Xing X; Du J; Zhang X; Jin L; Jiang L; Yao L; Li M; Wu J
Adv Sci (Weinh); 2023 Oct; 10(29):e2302298. PubMed ID: 37551034
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotection and axon regeneration by novel low-molecular-weight compounds through the modification of DOCK3 conformation.
Namekata K; Tsuji N; Guo X; Nishijima E; Honda S; Kitamura Y; Yamasaki A; Kishida M; Takeyama J; Ishikawa H; Shinozaki Y; Kimura A; Harada C; Harada T
Cell Death Discov; 2023 May; 9(1):166. PubMed ID: 37188749
[TBL] [Abstract][Full Text] [Related]
33. Consequences of exposure to pollutants on respiratory health: From genetic correlations to causal relationships.
D'Antona S; Castiglioni I; Porro D; Cava C
PLoS One; 2022; 17(11):e0277235. PubMed ID: 36395113
[TBL] [Abstract][Full Text] [Related]
34. DOCKopathies: A systematic review of the clinical pathologies associated with human DOCK pathogenic variants.
Samani A; English KG; Lopez MA; Birch CL; Brown DM; Kaur G; Worthey EA; Alexander MS
Hum Mutat; 2022 Sep; 43(9):1149-1161. PubMed ID: 35544951
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiological Mechanisms in Neurodevelopmental Disorders Caused by Rac GTPases Dysregulation: What's behind Neuro-RACopathies.
Scala M; Nishikawa M; Nagata KI; Striano P
Cells; 2021 Dec; 10(12):. PubMed ID: 34943902
[TBL] [Abstract][Full Text] [Related]
36. Genetic Predisposition to the Mortality in Septic Shock Patients: From GWAS to the Identification of a Regulatory Variant Modulating the Activity of a
Rosier F; Brisebarre A; Dupuis C; Baaklini S; Puthier D; Brun C; Pradel LC; Rihet P; Payen D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072601
[TBL] [Abstract][Full Text] [Related]
37. RHO to the DOCK for GDP disembarking: Structural insights into the DOCK GTPase nucleotide exchange factors.
Thompson AP; Bitsina C; Gray JL; von Delft F; Brennan PE
J Biol Chem; 2021; 296():100521. PubMed ID: 33684443
[TBL] [Abstract][Full Text] [Related]
38. Impact of integrated translational research on clinical exome sequencing.
Klee EW; Cousin MA; Pinto E Vairo F; Morales-Rosado JA; Macke EL; Jenkinson WG; Ferrer A; Schultz-Rogers LE; Olson RJ; Oliver GR; Sigafoos AN; Schwab TL; Zimmermann MT; Urrutia RA; Kaiwar C; Gupta A; Blackburn PR; Boczek NJ; Prochnow CA; Lowy RJ; Mulvihill LA; McAllister TM; Aoudia SL; Kruisselbrink TM; Gunderson LB; Kemppainen JL; Fisher LJ; Tarnowski JM; Hager MM; Kroc SA; Bertsch NL; Agre KE; Jackson JL; Macklin-Mantia SK; Murphree MI; Rust LM; Summer Bolster JM; Beck SA; Atwal PS; Ellingson MS; Barnett SS; Rasmussen KJ; Lahner CA; Niu Z; Hasadsri L; Ferber MJ; Marcou CA; Clark KJ; Pichurin PN; Deyle DR; Morava-Kozicz E; Gavrilova RH; Dhamija R; Wierenga KJ; Lanpher BC; Babovic-Vuksanovic D; Farrugia G; Schimmenti LA; Stewart AK; Lazaridis KN
Genet Med; 2021 Mar; 23(3):498-507. PubMed ID: 33144682
[TBL] [Abstract][Full Text] [Related]
39. DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies.
Reid AL; Wang Y; Samani A; Hightower RM; Lopez MA; Gilbert SR; Ianov L; Crossman DK; Dell'Italia LJ; Millay DP; van Groen T; Halade GV; Alexander MS
Hum Mol Genet; 2020 Oct; 29(17):2855-2871. PubMed ID: 32766788
[TBL] [Abstract][Full Text] [Related]
40. Variants in DOCK3 cause developmental delay and hypotonia.
Wiltrout K; Ferrer A; van de Laar I; Namekata K; Harada T; Klee EW; Zimmerman MT; Cousin MA; Kempainen JL; Babovic-Vuksanovic D; van Slegtenhorst MA; Aarts-Tesselaar CD; Schnur RE; Andrews M; Shinawi M
Eur J Hum Genet; 2019 Aug; 27(8):1225-1234. PubMed ID: 30976111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
